Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
Collecting duct water permeability inhibition by EGF is associated with decreased cAMP, PKA activity, and AQP2 phosphorylation at Ser(269)
Both Tirzepatide and Retatrutide are designed for once-weekly administration, indicating their extended half-lives in research models
Environ Sci Technol Lett 4:280285
BPC-157 is a subcutaneous (subQ) injection
US$ 24.97
US$ 23.61
US$ 23.44
US$ 24.76
US$ 26.43
US$ 20.01
US$ 24.25
